iNtRON Biotechnology, Inc. (048530.KQ)
KRW 5500.0
(-4.35%)
KRW 5500.0
(-4.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 9.58 Billion | 14 Billion | 29.3 Billion | 45.43 Billion | 8.34 Billion | 20.58 Billion |
| Cost of Revenue | 5.02 Billion | 5.55 Billion | 8.75 Billion | 20.15 Billion | 5.65 Billion | 6.12 Billion |
| Gross Profit | 4.56 Billion | 8.45 Billion | 20.55 Billion | 25.28 Billion | 2.68 Billion | 14.45 Billion |
| Operating Expenses | 7.84 Billion | 9.97 Billion | 10.91 Billion | 10.03 Billion | 7.91 Billion | 11.32 Billion |
| Selling, General and Administrative Expenses | 5.21 Billion | 7.12 Billion | 7.43 Billion | 6.55 Billion | 5.23 Billion | 6.04 Billion |
| Research and Development Expenses | 3.17 Billion | 2.84 Billion | 3.47 Billion | 3.47 Billion | 2.67 Billion | 5.28 Billion |
| Other Expenses | - | -2.58 Billion | -27.86 Million | -4.79 Billion | - | - |
| Cost and Expenses | 12.87 Billion | 15.52 Billion | 19.67 Billion | 30.18 Billion | 13.57 Billion | 17.45 Billion |
| Operating Income | -3.28 Billion | -1.52 Billion | 9.63 Billion | 15.25 Billion | -5.22 Billion | 3.12 Billion |
| Interest Expense | 2.91 Billion | 3.5 Billion | 1.63 Billion | 1.18 Billion | 957.13 Million | 152.64 Million |
| Income Tax Expense | -1.14 Billion | 2.6 Billion | 846.8 Million | 2.1 Billion | 1.27 Billion | -1.39 Billion |
| Earnings before Tax | -10.83 Billion | 8.14 Billion | 10.57 Billion | 17.05 Billion | -1.91 Billion | 7.31 Billion |
| Net Income | -9.69 Billion | 5.71 Billion | 9.72 Billion | 14.94 Billion | -3.18 Billion | 8.71 Billion |
| Earnings Per Share Basic | -292.11 | 168.38 | 288.42 | 476.32 | -106.43 | 290.89 |
| Earnings Per Share Diluted | -292.11 | -0.34 | 280.51 | 368.23 | -95.82 | 279.68 |
| Weighted Average Shares Outstanding | 33.19 Million | 33.92 Million | 33.72 Million | 31.38 Million | 29.94 Million | 29.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 33.19 Million | 36.02 Million | 34.68 Million | 34.13 Million | 33.26 Million | 31.14 Million |
| Gross Margin | 0.48 | 0.60 | 0.70 | 0.56 | 0.32 | 0.70 |
| EBIT Margin | -0.65 | 0.00 | 0.38 | 0.37 | -0.46 | 0.20 |
| Profit Margin | -1.01 | 0.41 | 0.33 | 0.33 | -0.38 | 0.42 |
| EBITDA | -6.23 Billion | 13.21 Billion | 13.74 Billion | 19.8 Billion | 465.87 Million | 8.4 Billion |
| Earnings Before Tax Margin | -0.34 | -0.11 | 0.33 | 0.34 | -0.63 | 0.15 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.77 Billion | 1.91 Billion | 3.71 Billion | 9.58 Billion | 1.67 Billion | 2.12 Billion |
| Cost of Revenue | 927.27 Million | 1.17 Billion | 1.41 Billion | 5.02 Billion | 1.22 Billion | 1.18 Billion |
| Gross Profit | 850.57 Million | 730.91 Million | 2.3 Billion | 4.56 Billion | 444.86 Million | 934.27 Million |
| Operating Expenses | 2 Billion | 1.84 Billion | 2.45 Billion | 7.84 Billion | 1.17 Billion | 1.96 Billion |
| Selling, General and Administrative Expenses | 1.16 Billion | 1.19 Billion | 1.8 Billion | - | 643.55 Million | 1.19 Billion |
| Research and Development Expenses | 837.29 Million | 649.07 Million | 655.86 Million | - | 534.79 Million | 762.71 Million |
| Other Expenses | -2.36 Billion | 5.37 Million | -753 Thousand | -317.16 Million | -192.96 Million | -559.51 Million |
| Cost and Expenses | 2.93 Billion | 3.02 Billion | 3.87 Billion | 12.87 Billion | 2.4 Billion | 3.14 Billion |
| Operating Income | -1.15 Billion | -1.11 Billion | -153.29 Million | -3.28 Billion | -733.48 Million | -1.02 Billion |
| Interest Expense | - | 6.24 Million | 4.96 Million | 2.91 Billion | 744.61 Million | 1.09 Billion |
| Income Tax Expense | -8.55 Million | -402.34 Million | 1.26 Billion | -1.14 Billion | -1.29 Billion | -370.77 Million |
| Earnings before Tax | 570.69 Million | -794.27 Million | -2.43 Billion | -11.06 Billion | -3.97 Billion | -2.32 Billion |
| Net Income | 579.25 Million | -375.81 Million | -3.7 Billion | -9.69 Billion | -2.59 Billion | -1.84 Billion |
| Earnings Per Share Basic | 17.46 | -11.66 | -111.56 | - | -78.09 | -55.66 |
| Earnings Per Share Diluted | 17.46 | -11.66 | -111.56 | - | -78.09 | -55.66 |
| Weighted Average Shares Outstanding | 33.18 Million | 32.23 Million | 33.19 Million | 33.19 Million | 33.19 Million | 33.19 Million |
| Weighted Average Shares Outstanding (Diluted) | 33.18 Million | 32.23 Million | 33.19 Million | 33.19 Million | 33.19 Million | 33.19 Million |
| Gross Margin | 0.48 | 0.38 | 0.62 | 0.48 | 0.27 | 0.44 |
| EBIT Margin | -0.36 | -0.31 | 0.10 | - | -0.15 | -0.29 |
| Profit Margin | 0.33 | -0.20 | -1.00 | -1.01 | -1.55 | -0.87 |
| EBITDA | -638.78 Million | -585.09 Million | 369.57 Million | - | -249.26 Million | -622.86 Million |
| Earnings Before Tax Margin | -0.65 | -0.58 | -0.04 | -0.34 | -0.44 | -0.48 |
RBRXF
BAS
DXIEF
ALNXT
HEBA-B
BTDR